Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Ohnishi, Kazunori
97  Ergebnisse:
OpenAccess-Volltexte X
?
1

Long‐term follow‐up after R‐High CHOP/CHASER/LEED with Auto..:

Ogura, Michinori ; Yamamoto, Kazuhito ; Morishima, Yasuo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394137/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

Clinical outcomes of second‐generation tyrosine kinase inhi..:

Ono, Takaaki ; Takahashi, Naoto ; Kizaki, Masahiro...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9986084/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
3

A multicenter, phase II study of full-dose THP-COP therapy ..:

Ohmachi, Ken ; Ogura, Michinori ; Kagami, Yoshitoyo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898716/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
4

A multicenter, phase II study of R-THP-COP therapy for elde..:

Ohnishi, Kazunori ; Ohmachi, Ken ; Ando, Kiyoshi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519245/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
5

Randomized study of imatinib for chronic myeloid leukemia: ..:

Miyamura, Koichi ; Ohnishi, Kazunori ; Ohtake, Shigeki...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373759/.  , 2019
Link: http://www.ncbi.nlm.nih...
 
?
6

R‐High‐CHOP/CHASER/LEED with autologous stem cell transplan..:

Ogura, Michinori ; Yamamoto, Kazuhito ; Morishima, Yasuo...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125440/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
7

Markedly improved outcomes and acceptable toxicity in adole..:

Hayakawa Fumihiko ; Sakura T ; Yujiri Toshiaki...
10.1038/bcj.2014.72.  , 2014
Link: http://hdl.handle.net/10..
 
?
8

The price of drugs for chronic myeloid leukemia (CML) is a ..:

Abboud, Camille ; Berman, Ellin ; Cohen, Adam...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC.  , 2013
Link: http://www.ncbi.nlm.nih...
 
?
9

Role of hematopoietic stem cell transplantation for relapse..:

Fujita, Hiroyuki ; Asou, Norio ; Iwanaga, Masako...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656542/.  , 2013
Link: http://www.ncbi.nlm.nih...
 
?
10

Phase I/II study of decitabine in patients with myelodyspla..:

Oki, Yasuhiro ; Kondo, Yutaka ; Yamamoto, Kazuhito...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7659334/.  , 2012
Link: http://www.ncbi.nlm.nih...
 
?
11

Long‐term outcome following imatinib therapy for chronic my..:

Ohnishi, Kazunori ; Nakaseko, Chiaki ; Takeuchi, Jin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685081/.  , 2012
Link: http://www.ncbi.nlm.nih...
 
?
12

INVOLVEMENT OF KRAS G12A MUTATION IN THE IL-2-INDEPENDENT G..:

MIZUTANI, NAOKI ; ITO, HIROMI ; HAGIWARA, KAZUMI...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831235/.  , 2012
Link: http://www.ncbi.nlm.nih...
 
?
13

Reduction of Raf Kinase Inhibitor Protein Expression by Bcr..:

Takemura, Tomonari ; Nakamura, Satoki ; Yokota, Daisuke...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2825454.  , 2010
Link: http://www.ncbi.nlm.nih...
 
?
14

Depletion of pleckstrin homology domain leucine-rich repeat..:

Hirano, Isao ; Nakamura, Satoki ; Yokota, Daisuke...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865270.  , 2010
Link: http://www.ncbi.nlm.nih...
 
?
15

Reduction of Raf kinase inhibitor protein expression by Bcr..:

Takemura, Tomonari ; Nakamura, Satoki ; Yokota, Daisuke...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2863203.  , 2010
Link: http://www.ncbi.nlm.nih...
 
1-15